China Drug R&D Sets On Tumors, Cardiovascular, Psychiatric Disorders
This article was originally published in PharmAsia News
Executive Summary
Recently released government figures show that China’s pharma R&D input totaled RMB 21.12 billion in 2011, constituting nearly 1.5% of GDP.